These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9728332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).
    Holme E, Lindstedt S.
    J Inherit Metab Dis; 1998 Aug; 21(5):507-17. PubMed ID: 9728331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).
    Pronicka E, Rowinska E, Bentkowski Z, Zawadzki J, Holme E, Lindstedt S.
    J Inherit Metab Dis; 1996 Aug; 19(2):234-8. PubMed ID: 8739974
    [No Abstract] [Full Text] [Related]

  • 7. Plasma antioxidant capacity in two cases of tyrosinaemia type 1: one case treated with NTBC.
    Bird S, Miller NJ, Collins JE, Rice-Evans CA.
    J Inherit Metab Dis; 1995 Aug; 18(2):123-6. PubMed ID: 7564225
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
    Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B.
    Lancet; 1992 Oct 03; 340(8823):813-7. PubMed ID: 1383656
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
    Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, Finegold M, Grompe M.
    Nat Genet; 1996 Mar 03; 12(3):266-73. PubMed ID: 8589717
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.
    Langlois C, Jorquera R, Finegold M, Shroads AL, Stacpoole PW, Tanguay RM.
    Biochem Pharmacol; 2006 May 28; 71(11):1648-61. PubMed ID: 16581029
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress.
    Dieter MZ, Freshwater SL, Miller ML, Shertzer HG, Dalton TP, Nebert DW.
    Free Radic Biol Med; 2003 Aug 15; 35(4):351-67. PubMed ID: 12899938
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.